Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RALTEGRAVIR vs RANIBIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RALTEGRAVIR vs RANIBIZUMAB: Safety Overview

Metric RALTEGRAVIR RANIBIZUMAB
Total FAERS Reports 8,612 15,284
Deaths Reported 985 2,651
Death Rate 11.4% 17.3%
Hospitalizations 2,088 2,265
Average Patient Age 43.5 yrs 71.7 yrs
% Female Patients 38.5% 52.5%
FDA Approval Date Dec 19, 2024 N/A
Manufacturer Proficient Rx LP Coherus BioSciences Inc
Route ORAL INTRAVITREAL
Marketing Status Prescription Prescription